Syneos Health, Inc. Class A Common Stock Underwriting AgreementUnderwriting Agreement • August 8th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
The stockholders named in Schedule II hereto (the “Selling Stockholders”) of Syneos Health, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Morgan Stanley & Co. LLC as set forth in Schedule I hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof, and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis) an aggregate of 6,000,000 shares (the “Shares”) of Class A Common Stock, par value $0.01 (“Stock”) of the Company.
DOUBLE EAGLE ACQUISITION SUB, INC., the GUARANTORS party hereto from time to time AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee 7.500% Senior Notes due 2024 INDENTURE Dated as of October 14, 2016Indenture • August 9th, 2017 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
INDENTURE dated as of October 14, 2016, among DOUBLE EAGLE ACQUISITION SUB, INC. (the “Issuer”), the Guarantors party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”).
INDEMNIFICATION And Advancement AGREEMENTIndemnification and Advancement Agreement • August 2nd, 2022 • Syneos Health, Inc. • Services-commercial physical & biological research • Delaware
This Indemnification and Advancement Agreement (“Agreement”) is made as of ________ __, 20__ by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and ______________, [a member of the Board of Directors/an officer/an employee/an agent/a fiduciary] of the Company (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering indemnification and advancement of expenses.
RECEIVABLES FINANCING AGREEMENT Dated as of June 29, 2018 by and among SYNEOS HEALTH RECEIVABLES LLC, as Borrower, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Lenders, PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent, INC RESEARCH, LLC, as...Receivables Financing Agreement • June 29th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
This RECEIVABLES FINANCING AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of June 29, 2018 by and among the following parties:
CREDIT AGREEMENT among INC RESEARCH, LLC, as Borrower, INC RESEARCH INTERMEDIATE, LLC, The Several Lenders from Time to Time Parties Hereto, GENERAL ELECTRIC CAPITAL CORPORATION, as Administrative Agent, ING CAPITAL LLC and ROYAL BANK OF CANADA, as...Credit Agreement • October 6th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of July 12, 2011, among INC RESEARCH, LLC, a Delaware limited liability company (the “Borrower”), INC RESEARCH INTERMEDIATE, LLC, a Delaware limited liability company (“Holdings”), the several banks and other financial institutions or entities from time to time parties to this Agreement as Lenders, GENERAL ELECTRIC CAPITAL CORPORATION, as administrative agent and collateral agent (in such capacities, and together with its successors and permitted assigns in such capacities, the “Administrative Agent” and the “Collateral Agent,” respectively) and Swingline Lender, ING CAPITAL LLC and ROYAL BANK OF CANADA, as co-syndication agents (in such capacity, the “Co-Syndication Agents”), NATIXIS, as documentation agent (in such capacity, the “Documentation Agent”) and GENERAL ELECTRIC CAPITAL CORPORATION, as Issuing Lender.
CREDIT AGREEMENT among INC RESEARCH, LLC, as Borrower, INC RESEARCH HOLDINGS, INC., The Several Lenders from Time to Time Parties Hereto, GOLDMAN SACHS BANK USA, as Administrative Agent, GOLDMAN SACHS BANK USA, as Collateral Agent, GOLDMAN SACHS BANK...Credit Agreement • February 24th, 2015 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of November 13, 2014, among INC RESEARCH, LLC, a Delaware limited liability company (the “Borrower”), INC RESEARCH HOLDINGS, INC., a Delaware corporation (“Holdings”), the several banks and other financial institutions or entities from time to time parties to this Agreement as Lenders and GOLDMAN SACHS BANK USA, as administrative agent and collateral agent (in such capacities, and together with its successors and permitted assigns in such capacities, the “Administrative Agent” and the “Collateral Agent,” respectively) and Swingline Lender.
CREDIT AGREEMENT Dated as of August 1, 2017 among INC RESEARCH HOLDINGS, INC., as the Administrative Borrower, the other BORROWERS party hereto, THE FINANCIAL INSTITUTIONS PARTY HERETO, as Lenders, CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH as...Credit Agreement • August 1st, 2017 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
CREDIT AGREEMENT, dated as of August 1, 2017 (this “Agreement”), by and among INC Research Holdings, Inc., a Delaware corporation (“INC Holdings” or the “Administrative Borrower”), the entities listed on Schedule I hereto (each a “Borrower” and collectively with the Administrative Borrower, the “Borrowers”), the Lenders from time to time party hereto, Credit Suisse AG, Cayman Islands Branch (“Credit Suisse”), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), and Credit Suisse Securities (USA) LLC (“CS Securities”), ING Capital LLC (“ING”), Goldman Sachs Bank USA, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley Senior Funding, Inc., Barclays Bank PLC, Citigroup Global Markets Inc., Fifth Third Bank, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC and Regions Capital Markets, a Division of Regions Bank, SunTrust Robinson Humphrey, Inc., The Bank of Tokyo-Mitsubishi UFJ, Ltd. and Wells Fargo Securities, LLC
INC Research Holdings, Inc. Class A Common Stock Form of Underwriting AgreementINC Research Holdings, Inc. • August 11th, 2015 • Services-commercial physical & biological research • New York
The stockholders named in Schedule II hereto (the “Selling Stockholders”) of INC Research Holdings, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [●] shares (the “Shares”) of Class A Common Stock, par value $0.01 (“Stock”) of the Company.
Syneos Health, Inc. Class A Common Stock Underwriting AgreementUnderwriting Agreement • June 4th, 2021 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
The stockholders named in Schedule II hereto (the “Selling Stockholders”) of Syneos Health, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to BofA Securities, Inc. (“BofA Securities”) as set forth in Schedule I hereto (the “Underwriter”) an aggregate of 10,851,676 shares (the “Shares”) of Class A Common Stock, par value $0.01 (“Stock”) of the Company.
AGREEMENT AND PLAN OF MERGER BY AND AMONG STAR PARENT, INC., STAR MERGER SUB, INC. AND SYNEOS HEALTH, INC. MAY 10, 2023Agreement and Plan of Merger • May 10th, 2023 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 10, 2023, is entered into by and among Syneos Health, Inc., a Delaware corporation (the “Company”), Star Parent, Inc., a Delaware corporation (“Parent”), and Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
SYNEOS HEALTH, INC. 2018 Equity Incentive Plan Global Restricted Stock Unit Award AgreementGlobal Restricted Stock Unit Award Agreement • May 10th, 2023 • Syneos Health, Inc. • Services-commercial physical & biological research • Colorado
The RSUs are an extraordinary benefit, which for labor law purposes (e.g., thirteenth month salary, Christmas bonuses, or similar payments) are valued at the fair market value of the Shares on the date of vesting, when the Shares are delivered to the Participant. Such value is inclusive of thirteenth month salary for the month in which the vesting occurs.
PURCHASE AND SALE AGREEMENT Dated as of June 29, 2018 among VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO, as Originators, INC RESEARCH, LLC, as Servicer, and SYNEOS HEALTH RECEIVABLES LLC, as BuyerPurchase and Sale Agreement • June 29th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
This PURCHASE AND SALE AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of June 29, 2018 is entered into among the VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO (the “Originators” and each, an “Originator”), INC RESEARCH, LLC, a Delaware limited liability company, as initial Servicer (as defined below) (“INC Research”), and SYNEOS HEALTH RECEIVABLES LLC, a Delaware limited liability company (the “Buyer”).
SYNEOS HEALTH, INC. 2018 Equity Incentive Plan Global Performance Restricted Stock Unit Award AgreementRestricted Stock Unit Award Agreement • February 16th, 2023 • Syneos Health, Inc. • Services-commercial physical & biological research • Delaware
This Global Performance Restricted Stock Unit Award Agreement including any special terms and conditions for the Participant’s country set forth in Appendix B, attached hereto (the Global Performance Restricted Stock Unit Agreement, the Appendix B and all other appendices attached hereto, collectively, the “Agreement”), is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and [Participant Name] (the “Participant”), effective as of [Grant Date] (the “Date of Grant”).
CREDIT AGREEMENT among INC RESEARCH, LLC, as Borrower, INC RESEARCH HOLDINGS, INC., The Several Lenders from Time to Time Parties Hereto, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent,Credit Agreement • May 15th, 2015 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of May 14, 2015, among INC RESEARCH, LLC, a Delaware limited liability company (the “Borrower”), INC RESEARCH HOLDINGS, INC., a Delaware corporation (“Holdings”), the several banks and other financial institutions or entities from time to time parties to this Agreement as Lenders and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent and collateral agent (in such capacities, and together with its successors and permitted assigns in such capacities, the “Administrative Agent” and the “Collateral Agent,” respectively) and Swingline Lender.
ContractExecutive Employment Agreement • February 25th, 2016 • INC Research Holdings, Inc. • Services-commercial physical & biological research • North Carolina
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of the 31st day of July, 2014 (the “Effective Date”) by and between INC Research, LLC (the “Company”), and Michael Gibertini, an executive employee of the Company (“Executive”).
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan Stock Option Award Agreement for U.S. ParticipantsStock Option Award Agreement • October 17th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This Stock Option Award Agreement for U.S. Participants (this “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and [·] (the “Participant”), effective as of [·] (the “Date of Grant”).
AMENDMENT NO. 5Credit Agreement • July 1st, 2021 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of August 1, 2017 (this “Agreement”), by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), a Delaware corporation (“INC Holdings” or the “Administrative Borrower”), the entities listed on Schedule I hereto (each a “Borrower” and collectively with the Administrative Borrower, the “Borrowers”), the Lenders from time to time party hereto, JPMorgan Chase Bank, N.A. (as successor to Credit Suisse AG, Cayman Islands Branch (“Credit Suisse”)), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), and ING Capital LLC (“ING”), Goldman Sachs Bank USA, BofA Securities, Inc. Morgan Stanley Senior Funding, Inc., Citibank, N.A., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, Regions Capital Markets, a Division of Regions Bank, MUFG Bank, Ltd. and Wells Fargo Securities, LLC, Truist Securities, Inc., Keybank National Association and TD Securities (USA) LLC,
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan Stock Option Award Agreement for Non-U.S. ParticipantsStock Option Award Agreement • October 29th, 2015 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This Stock Option Award Agreement for Non-U.S. Participants (the “Option Agreement”), including any special terms and conditions for the Participant’s country set forth in the appendix attached hereto (the “Appendix”) (the Option Agreement and the Appendix, together, this “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and [●] (the “Participant”), effective as of [●] (the “Date of Grant”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • June 4th, 2021 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of June 1, 2021 by and between Syneos Health, Inc., a Delaware corporation (the “Company”), Thomas H. Lee Equity Fund VII, L.P., Thomas H. Lee Parallel Fund VII, L.P., THL Executive Fund VII, L.P., THL Fund VII Coinvestment Partners, L.P., THL Equity Fund VII Investors (inVentiv), L.P., Thomas H. Lee Equity Fund VI (2019), L.P., THL Fund VI (2019) Coinvestment Partners, L.P., THL Managers VI, LLC and THL Managers VII, LLC (collectively, the “THL Funds”) and Double Eagle Investor Holdings, L.P. and Advent International GPE VIII-C Limited Partnership (together, the “Advent Funds”, and collectively with the THL Funds, the “Sellers”).
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan Restricted Stock Award AgreementRestricted Stock Award Agreement • October 17th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This Restricted Stock Award Agreement (this “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and [·] (the “Participant”), effective as of [·] (the “Date of Grant”).
GUARANTEE AND COLLATERAL AGREEMENT made by INC RESEARCH, LLC INC RESEARCH HOLDINGS, INC. and the other signatories hereto in favor of GOLDMAN SACHS BANK USA, as Collateral Agent and GOLDMAN SACHS BANK USA, as Administrative Agent Dated as of November...Guarantee and Collateral Agreement • February 24th, 2015 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
GUARANTEE AND COLLATERAL AGREEMENT, dated as of November 13, 2014, made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Grantors” and, excluding the Borrower, the “Guarantors”), in favor of GOLDMAN SACHS BANK USA, as collateral agent (in such capacity, the “Collateral Agent”) and GOLDMAN SACHS BANK USA, as administrative agent (in such capacity, the “Administrative Agent”), for the Secured Parties (as defined in the Credit Agreement referred to below).
TRANSITION AGREEMENTTransition Agreement • July 28th, 2016 • INC Research Holdings, Inc. • Services-commercial physical & biological research • North Carolina
This TRANSITION AGREEMENT (this “Agreement”) by and among Duncan Jamie Macdonald (the “Executive”), INC Research, LLC (the “LLC”) and INC Research Holdings, Inc. (the “Company”) (the “Parties”) is entered into as of July 27, 2016 (the “Effective Date”).
SECOND AMENDED & RESTATED STOCKHOLDERS AGREEMENT DATED AS OF NOVEMBER 6, 2014 AMONG INC RESEARCH HOLDINGS, INC. AVISTA CAPITAL PARTNERS II, L.P. AVISTA CAPITAL PARTNERS (OFFSHORE) II, L.P. AVISTA CAPITAL PARTNERS (OFFSHORE) II-A, L.P. 1829356 ONTARIO...Stockholders Agreement • November 14th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
THIS SECOND AMENDED & RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), dated as of November 6, 2014, amends and restates in its entirety that certain Amended and Restated Stockholders Agreement, dated as of July 12, 2011 (the “Previous Agreement”), among INC Research Holdings, Inc. (f/k/a Triangle Acquisition Holdings Inc.), a Delaware corporation (together with its successors, the “Company”), Avista Capital Partners II, L.P., a Delaware limited partnership (“Avista”), Avista Capital Partners (Offshore) II, L.P., a Bermuda exempted limited partnership, Avista Capital Partners (Offshore) II-A, L.P., a Bermuda exempted limited partnership (collectively, the “Avista Funds”), 1829356 Ontario Limited, a corporation formed under the laws of the Province of Ontario and wholly-owned subsidiary of OTPP (as defined below), (“CapitalCo”; and each of CapitalCo, on the one hand, and the Avista Funds, collectively, on the other hand, a “Sponsor”), ACP INC Research Co-Invest, LLC, a Delaware limit
CONSULTING AGREEMENTConsulting Agreement • December 10th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • Massachusetts
This Consulting Agreement (hereinafter “Agreement”), effective as of December 10, 2018 (“Effective Date”), by and between Syneos Health, Inc. (hereinafter “Syneos Health” or the “Company”), a Delaware company, with principal offices located at 1030 Sync Street, Morrisville, North Carolina 27560, and Michael Bell (hereinafter “Bell” or “Consultant”), located at [personal address].
LEASE AMENDMENT NUMBER THREELease Amendment Number Three • October 6th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research
This LEASE AMENDMENT NUMBER THREE entered into this 4th day of January, 2013 (the “Third Amendment”), by and between HIGHWOODS REALTY LIMITED PARTNERSHIP, a North Carolina limited partnership (the “Landlord”) and INC RESEARCH, LLC, a Delaware limited liability company (“Tenant”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • August 18th, 2016 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of August 12, 2016 by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), Avista Capital Partners II, L.P., a Delaware limited partnership (“Avista”), Avista Capital Partners (Offshore) II, L.P., a Bermuda exempted limited partnership, Avista Capital Partners (Offshore) II-A, L.P., a Bermuda exempted limited partnership (collectively, the “Avista Funds”), 1829356 Ontario Limited, a corporation formed under the laws of the Province of Ontario and wholly-owned subsidiary of Ontario Teachers’ Pension Plan Board (“Teachers”), ACP INC Research Co-Invest, LLC, a Delaware limited liability company (the “Avista Syndication Vehicle”), INC Research Mezzanine Co-Invest, LLC, a Delaware limited liability company (the “Mezzanine Co-Invest Vehicle”) (collectively, the “Sellers”).
DATED 27 July 2016 and EXECUTIVE SERVICE AGREEMENTExecutive Service Agreement • July 28th, 2016 • INC Research Holdings, Inc. • Services-commercial physical & biological research • England and Wales
LEASE AMENDMENT NUMBER TWOLease Amendment Number Two • October 6th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research
This LEASE AMENDMENT NUMBER TWO entered into this 23rd day of August, 2011 (the “Second Amendment”), by and between HIGHWOODS REALTY LIMITED PARTNERSHIP, a North Carolina limited partnership (the “Landlord”) and INC RESEARCH, LLC, a Delaware limited liability company, successor-in-interest to INC Research, Inc. (the “Tenant”).
Page ARTICLE I DEFINITIONS 1 ARTICLE II TRANSFER RESTRICTIONS 9 Section 2.1 Transfer Restrictions 9 Section 2.2 Legend 11 Section 2.3 Rule 144 Transfers 11 ARTICLE III REGISTRATION RIGHTS 12 Section 3.1 Demand Registration 12 Section 3.2 Piggyback...Stockholders’ Agreement • May 10th, 2017 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This STOCKHOLDERS’ AGREEMENT (this “Agreement”) is made as of May 10, 2017 by and among INC Research Holdings, Inc., a Delaware corporation (the “Company”), Double Eagle Investor Holdings, L.P. and Advent International GPE VIII-C Limited Partnership (together, the “Stockholder”), and each other Person who after the date hereof becomes a party hereto. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the Merger Agreement (as herein defined).
FOR USE IN U.S. FOR EXECUTIVES WITH EMPLOYMENT AGREEMENT] INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan Performance Restricted Stock Unit Award AgreementPerformance Restricted Stock Unit Award Agreement • May 2nd, 2016 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This Performance Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and Participant Name (the “Participant”), effective as of Grant Date (the “Date of Grant”).
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan, As Amended and Restated Global Performance Restricted Stock Unit Award AgreementGlobal Performance Restricted Stock Unit Award Agreement • May 9th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • Delaware
This Global Performance Restricted Stock Unit Award Agreement including any special terms and conditions for the Participant’s country set forth in Appendix B, attached hereto (the Global Performance Restricted Stock Unit Agreement and Appendix A and B, together, the “Agreement”) is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and Participant Name (the “Participant”), effective as of Grant Date (the “Date of Grant”).
GUARANTEE AND COLLATERAL AGREEMENT made by INC RESEARCH, LLC INC RESEARCH INTERMEDIATE, LLC and the other signatories hereto in favor of GENERAL ELECTRIC CAPITAL CORPORATION, as Collateral Agent and GENERAL ELECTRIC CAPITAL CORPORATION, as...Patent Security Agreement • October 6th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research • New York
GUARANTEE AND COLLATERAL AGREEMENT, dated as of July 12, 2011, made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Grantors” and, excluding the Borrower, the “Guarantors”), in favor of GENERAL ELECTRIC CAPITAL CORPORATION, as collateral agent (in such capacity, the “Collateral Agent”) and GENERAL ELECTRIC CAPITAL CORPORATION, as administrative agent (in such capacity, the “Administrative Agent”), for the Secured Parties (as defined in the Credit Agreement referred to below).
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan Stock Option Award Agreement for U.S. ParticipantsStock Option Award Agreement • October 29th, 2015 • INC Research Holdings, Inc. • Services-commercial physical & biological research • Delaware
This Stock Option Award Agreement for U.S. Participants (this “Agreement”) is made by and between INC Research Holdings, Inc., a Delaware corporation (the “Company”), and [●] (the “Participant”), effective as of [●] (the “Date of Grant”).
EXECUTIVE SERVICE AGREEMENTExecutive Service Agreement • October 6th, 2014 • INC Research Holdings, Inc. • Services-commercial physical & biological research
INC RESEARCH HOLDINGS, INC. 2014 Equity Incentive Plan, As Amended and Restated Global Restricted Stock Unit Award AgreementGlobal Restricted Stock Unit Award Agreement • May 9th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • Delaware
This Global Restricted Stock Unit Award Agreement (the “Restricted Stock Unit Agreement”), including any special terms and conditions for the Participant’s country set forth in the Appendix A attached hereto (the Restricted Stock Unit Agreement and the Appendix A collectively, the “Agreement”) is made by and between Syneos Health, Inc., a Delaware corporation (the “Company”), and Participant Name (the “Participant”), effective as of Grant Date (the “Date of Grant”).
